Literature DB >> 34355196

Medical School Hotline: Immunoepigenetic-Microbiome Axis: Implications for Health Disparities Research in Native Hawaiians and Pacific Islanders.

Noelle C Rubas1, Alika Maunakea1.   

Abstract

Native Hawaiian and Pacific Islander (NHPI) populations suffer from disproportionately higher rates of chronic conditions, such as type 2 diabetes, that arises from metabolic dysfunction and are often associated with obesity and inflammation. In addition, the global coronavirus disease 2019 pandemic has further compounded the effect of health inequities observed in Indigenous populations, including NHPI communities. Reversible lifestyle habits, such as diet, may either be protective of or contribute to the increasing prevalence of health inequities in these populations via the immunoepigenetic-microbiome axis. This axis offers insight into the connection between diet, epigenetics, the microbiome composition, immune function, and response to viral infection. Epigenetic mechanisms that regulate inflammatory states associated with metabolic diseases, including diabetes, are impacted by diet. Furthermore, diet may modulate the gut microbiome by influencing microbial diversity and richness; dysbiosis of the microbiome is associated with chronic disease. A high fiber diet facilitates a favorable microbiome composition and in turn increases production of intermediate metabolites named short-chain fatty acids (SCFAs) that act on metabolic and immune pathways. In contrast, low fiber diets typically associated with a westernized lifestyle decreases the abundance of microbial derived SCFAs. This decreased abundance is characteristic of metabolic syndromes and activation of chronic inflammatory states, having larger implications in disease pathogenesis of both communicable and non-communicable diseases. Native Hawaiians and Pacific Islanders that once thrived on healthy traditional diets may be more sensitive than non-indigenous peoples to the metabolic perturbation of westernized diets that impinge on the immunoepigenetic-gut microbiome axis. Recent studies conducted in the Maunakea lab at the University of Hawai'i at Mānoa John A. Burns School of Medicine have helped elucidate the connections between diet, microbiome composition, metabolic syndrome, and epigenetic regulation of immune function to better understand disease pathogenesis. Potentially, this research could point to ways to prevent pre-disease conditions through novel biomarker discovery using community-based approaches. ©Copyright 2021 by University Health Partners of Hawai‘i (UHP Hawai‘i).

Entities:  

Keywords:  COVID-19 severity; SARS-CoV-2; ethnic health disparities; immunoepigenetic-microbiome axis; intestinal microbiome; metabolic syndrome; short-chain fatty acid; type II diabetes risk

Mesh:

Substances:

Year:  2021        PMID: 34355196      PMCID: PMC8334073     

Source DB:  PubMed          Journal:  Hawaii J Health Soc Welf        ISSN: 2641-5216


  9 in total

1.  COVID-19 Special Column: COVID-19 Hits Native Hawaiian and Pacific Islander Communities the Hardest.

Authors:  Joseph Keawe'aimoku Kaholokula; Raynald A Samoa; Robin E S Miyamoto; Neal Palafox; Sheri-Ann Daniels
Journal:  Hawaii J Health Soc Welf       Date:  2020-05-01

2.  The metabolic syndrome and inflammation: association or causation?

Authors:  K Esposito; D Giugliano
Journal:  Nutr Metab Cardiovasc Dis       Date:  2004-10       Impact factor: 4.222

Review 3.  Diabetes Disparities and Promising Interventions to Address Diabetes in Native Hawaiian and Pacific Islander Populations.

Authors:  Pearl A McElfish; Rachel S Purvis; Monica K Esquivel; Ka'imi A Sinclair; Claire Townsend; Nicola L Hawley; Lauren K Haggard-Duff; Joseph Keawe'aimoku Kaholokula
Journal:  Curr Diab Rep       Date:  2019-03-18       Impact factor: 4.810

Review 4.  Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation.

Authors:  Knud Erik Bach Knudsen; Helle Nygaard Lærke; Mette Skou Hedemann; Tina Skau Nielsen; Anne Krog Ingerslev; Ditte Søvsø Gundelund Nielsen; Peter Kappel Theil; Stig Purup; Stine Hald; Anne Grethe Schioldan; Maria L Marco; Søren Gregersen; Kjeld Hermansen
Journal:  Nutrients       Date:  2018-10-13       Impact factor: 5.717

Review 5.  Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.

Authors:  Daniela Parada Venegas; Marjorie K De la Fuente; Glauben Landskron; María Julieta González; Rodrigo Quera; Gerard Dijkstra; Hermie J M Harmsen; Klaas Nico Faber; Marcela A Hermoso
Journal:  Front Immunol       Date:  2019-03-11       Impact factor: 7.561

Review 6.  Gut Microbiome: Profound Implications for Diet and Disease.

Authors:  Ronald D Hills; Benjamin A Pontefract; Hillary R Mishcon; Cody A Black; Steven C Sutton; Cory R Theberge
Journal:  Nutrients       Date:  2019-07-16       Impact factor: 5.717

Review 7.  Regulation of immune cell function by short-chain fatty acids.

Authors:  Renan Corrêa-Oliveira; José Luís Fachi; Aline Vieira; Fabio Takeo Sato; Marco Aurélio R Vinolo
Journal:  Clin Transl Immunology       Date:  2016-04-22

Review 8.  Diet, Microbiota and Gut-Lung Connection.

Authors:  Swadha Anand; Sharmila S Mande
Journal:  Front Microbiol       Date:  2018-09-19       Impact factor: 5.640

Review 9.  SARS-CoV-2 morbidity and mortality in racial/ethnic minority populations: A window into the stress related inflammatory basis of health disparities?

Authors:  Bizu Gelaye; Simmie Foster; Manoj Bhasin; Ahmed Tawakol; Gregory Fricchione
Journal:  Brain Behav Immun Health       Date:  2020-10-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.